InsiderTrades.com logo
Nikhil Lalwani net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Nikhil Lalwani Biography and Net Worth

President and Chief Executive Officer of ANI Pharmaceuticals

Mr. Lalwani is ANI’s President and Chief Executive Officer and a member of ANI’s Board. Prior to joining ANI in September 2020, Mr. Lalwani worked at Cipla Ltd (NSE: CIPLA), a global pharmaceutical company, from May 2012 to August 2020 where he held positions of increasing responsibility, including CEO of Cipla USA, CEO of InvaGen, Head of US Strategy, M&A & Integration, and Head of Cipla’s Global Respiratory business. In these roles, Mr. Lalwani developed and executed multi-year strategic growth plans for key products and facilitated successful acquisitions as Cipla entered the specialty pharmaceutical space. Prior to Cipla, Mr. Lalwani was an Associate Partner with McKinsey & Company serving pharmaceutical and healthcare companies across the world, and an engineer with Medtronic. Mr. Lalwani holds a B.S. in Electrical Engineering from Georgia Institute of Technology and an M.B.A. from the Wharton School at the University of Pennsylvania.

What is Nikhil Lalwani's net worth?

The estimated net worth of Nikhil Lalwani is at least $25.04 million as of November 26th, 2024. Mr. Lalwani owns 370,378 shares of ANI Pharmaceuticals stock worth more than $25,041,257 as of March 29th. This net worth approximation does not reflect any other investments that Mr. Lalwani may own. Additionally, Mr. Lalwani receives an annual salary of $2,320,000.00 as President and Chief Executive Officer at ANI Pharmaceuticals. Learn More about Nikhil Lalwani's net worth.

How old is Nikhil Lalwani?

Mr. Lalwani is currently 46 years old. There are 8 older executives and no younger executives at ANI Pharmaceuticals. Learn More on Nikhil Lalwani's age.

What is Nikhil Lalwani's salary?

As the President and Chief Executive Officer of ANI Pharmaceuticals, Inc., Mr. Lalwani earns $2,320,000.00 per year. Learn More on Nikhil Lalwani's salary.

How do I contact Nikhil Lalwani?

The corporate mailing address for Mr. Lalwani and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at ir@anipharmaceuticals.com. Learn More on Nikhil Lalwani's contact information.

Has Nikhil Lalwani been buying or selling shares of ANI Pharmaceuticals?

Nikhil Lalwani has not been actively trading shares of ANI Pharmaceuticals over the course of the past ninety days. Most recently, Nikhil Lalwani sold 33,481 shares of the business's stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $57.99, for a transaction totalling $1,941,563.19. Following the completion of the sale, the chief executive officer now directly owns 370,378 shares of the company's stock, valued at $21,478,220.22. Learn More on Nikhil Lalwani's trading history.

Who are ANI Pharmaceuticals' active insiders?

ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Stephen Carey (Senior Vice President, Finance and Chief Financial Officer), Meredith Cook (Senior Vice President, General Counsel and Corporate Secretary), Krista Davis (Senior Vice President and Chief Human Resources Officer), Chad Gassert (Senior Vice President, Corporate Development and Strategy), Ori Gutwerg (Senior Vice President, Generics), Thomas Haughey (Director), Nikhil Lalwani (Pres), Nikhil Lalwani (President and Chief Executive Officer), James Marken (Senior Vice President, Operations and Product Development), Christopher Mutz (Insider), Antonio Pera (Director), Muthusamy Shanmugam (Head of R&D and COO of NJ Operations), Muthusamy Shanmugam (Head of R&D and COO), Renee Tannenbaum (Director), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.

Are insiders buying or selling shares of ANI Pharmaceuticals?

During the last year, insiders at the specialty pharmaceutical company sold shares 33 times. They sold a total of 268,126 shares worth more than $16,946,714.15. The most recent insider tranaction occured on March, 13th when VP Meredith Cook sold 400 shares worth more than $25,332.00. Insiders at ANI Pharmaceuticals own 12.7% of the company. Learn More about insider trades at ANI Pharmaceuticals.

Information on this page was last updated on 3/13/2025.

Nikhil Lalwani Insider Trading History at ANI Pharmaceuticals

See Full Table

Nikhil Lalwani Buying and Selling Activity at ANI Pharmaceuticals

This chart shows Nikhil Lalwani's buying and selling at ANI Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M$0$2MTotal Insider BuyingTotal Insider Selling

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals logo
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Read More

Today's Range

Now: $67.61
Low: $67.02
High: $68.49

50 Day Range

MA: $60.49
Low: $54.51
High: $68.36

2 Week Range

Now: $67.61
Low: $52.50
High: $70.00

Volume

355,964 shs

Average Volume

256,304 shs

Market Capitalization

$1.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63